Market Cap
$147,998,967,579
Enterprise Value
$192,589,967,579
Average Volume
$68,054,510
PFIZER INC - PFE
$26.03
+0.34
(1.30%)
Valuation & Solvency
P/Tangible Book
1.59
P/E
15.07
P/S
2.36
EV/EBITDA
9.10
EV/Sales
3.07
EV/FCF
18.56
Dividend Yield
6.61%
Payout Ratio
98.83%
Total Debt
$61,712,000,000
Cash & Marketable Securities
$14,984,000,000
Quick Ratio
0.97
Debt/Equity
0.66
Net Debt/EBITDA
2.11
Interest Coverage Ratio
6.47
About
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
US
Beta
0.42
Company Description
▶
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.